Copyright Reports & Markets. All rights reserved.

Global Recombinant DNA Vaccine Market Research Report 2021

Request for Sample of this report
Buy now

1 Recombinant DNA Vaccine Market Overview

  • 1.1 Product Overview and Scope of Recombinant DNA Vaccine
  • 1.2 Recombinant DNA Vaccine Segment by Type
    • 1.2.1 Global Recombinant DNA Vaccine Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Recombinant Protein Vaccine
    • 1.2.3 Gene-Based Vaccine
  • 1.3 Recombinant DNA Vaccine Segment by Application
    • 1.3.1 Recombinant DNA Vaccine Sales Comparison by Application: (2021-2027)
    • 1.3.2 Human
    • 1.3.3 Animal
  • 1.4 Global Recombinant DNA Vaccine Market Size Estimates and Forecasts
    • 1.4.1 Global Recombinant DNA Vaccine Revenue 2016-2027
    • 1.4.2 Global Recombinant DNA Vaccine Sales 2016-2027
    • 1.4.3 Recombinant DNA Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Recombinant DNA Vaccine Market Competition by Manufacturers

  • 2.1 Global Recombinant DNA Vaccine Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Recombinant DNA Vaccine Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Recombinant DNA Vaccine Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Recombinant DNA Vaccine Manufacturing Sites, Area Served, Product Type
  • 2.5 Recombinant DNA Vaccine Market Competitive Situation and Trends
    • 2.5.1 Recombinant DNA Vaccine Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Recombinant DNA Vaccine Players Market Share by Revenue
    • 2.5.3 Global Recombinant DNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Recombinant DNA Vaccine Retrospective Market Scenario by Region

  • 3.1 Global Recombinant DNA Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Recombinant DNA Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Recombinant DNA Vaccine Market Facts & Figures by Country
    • 3.3.1 North America Recombinant DNA Vaccine Sales by Country
    • 3.3.2 North America Recombinant DNA Vaccine Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Recombinant DNA Vaccine Market Facts & Figures by Country
    • 3.4.1 Europe Recombinant DNA Vaccine Sales by Country
    • 3.4.2 Europe Recombinant DNA Vaccine Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Recombinant DNA Vaccine Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Recombinant DNA Vaccine Sales by Region
    • 3.5.2 Asia Pacific Recombinant DNA Vaccine Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Recombinant DNA Vaccine Market Facts & Figures by Country
    • 3.6.1 Latin America Recombinant DNA Vaccine Sales by Country
    • 3.6.2 Latin America Recombinant DNA Vaccine Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Recombinant DNA Vaccine Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Recombinant DNA Vaccine Sales by Country
    • 3.7.2 Middle East and Africa Recombinant DNA Vaccine Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Recombinant DNA Vaccine Historic Market Analysis by Type

  • 4.1 Global Recombinant DNA Vaccine Sales Market Share by Type (2016-2021)
  • 4.2 Global Recombinant DNA Vaccine Revenue Market Share by Type (2016-2021)
  • 4.3 Global Recombinant DNA Vaccine Price by Type (2016-2021)

5 Global Recombinant DNA Vaccine Historic Market Analysis by Application

  • 5.1 Global Recombinant DNA Vaccine Sales Market Share by Application (2016-2021)
  • 5.2 Global Recombinant DNA Vaccine Revenue Market Share by Application (2016-2021)
  • 5.3 Global Recombinant DNA Vaccine Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Merck
    • 6.1.1 Merck Corporation Information
    • 6.1.2 Merck Description and Business Overview
    • 6.1.3 Merck Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Merck Product Portfolio
    • 6.1.5 Merck Recent Developments/Updates
  • 6.2 GSK
    • 6.2.1 GSK Corporation Information
    • 6.2.2 GSK Description and Business Overview
    • 6.2.3 GSK Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 GSK Product Portfolio
    • 6.2.5 GSK Recent Developments/Updates
  • 6.3 Sanofi
    • 6.3.1 Sanofi Corporation Information
    • 6.3.2 Sanofi Description and Business Overview
    • 6.3.3 Sanofi Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Sanofi Product Portfolio
    • 6.3.5 Sanofi Recent Developments/Updates
  • 6.4 Zoties
    • 6.4.1 Zoties Corporation Information
    • 6.4.2 Zoties Description and Business Overview
    • 6.4.3 Zoties Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Zoties Product Portfolio
    • 6.4.5 Zoties Recent Developments/Updates
  • 6.5 Elanco
    • 6.5.1 Elanco Corporation Information
    • 6.5.2 Elanco Description and Business Overview
    • 6.5.3 Elanco Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Elanco Product Portfolio
    • 6.5.5 Elanco Recent Developments/Updates
  • 6.6 Boehringer-Ingelheim
    • 6.6.1 Boehringer-Ingelheim Corporation Information
    • 6.6.2 Boehringer-Ingelheim Description and Business Overview
    • 6.6.3 Boehringer-Ingelheim Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Boehringer-Ingelheim Product Portfolio
    • 6.6.5 Boehringer-Ingelheim Recent Developments/Updates
  • 6.7 Indian Immunologicals
    • 6.6.1 Indian Immunologicals Corporation Information
    • 6.6.2 Indian Immunologicals Description and Business Overview
    • 6.6.3 Indian Immunologicals Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Indian Immunologicals Product Portfolio
    • 6.7.5 Indian Immunologicals Recent Developments/Updates
  • 6.8 Plumbline Life Sciences
    • 6.8.1 Plumbline Life Sciences Corporation Information
    • 6.8.2 Plumbline Life Sciences Description and Business Overview
    • 6.8.3 Plumbline Life Sciences Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Plumbline Life Sciences Product Portfolio
    • 6.8.5 Plumbline Life Sciences Recent Developments/Updates

7 Recombinant DNA Vaccine Manufacturing Cost Analysis

  • 7.1 Recombinant DNA Vaccine Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Recombinant DNA Vaccine
  • 7.4 Recombinant DNA Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Recombinant DNA Vaccine Distributors List
  • 8.3 Recombinant DNA Vaccine Customers

9 Recombinant DNA Vaccine Market Dynamics

  • 9.1 Recombinant DNA Vaccine Industry Trends
  • 9.2 Recombinant DNA Vaccine Growth Drivers
  • 9.3 Recombinant DNA Vaccine Market Challenges
  • 9.4 Recombinant DNA Vaccine Market Restraints

10 Global Market Forecast

  • 10.1 Recombinant DNA Vaccine Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Recombinant DNA Vaccine by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Recombinant DNA Vaccine by Type (2022-2027)
  • 10.2 Recombinant DNA Vaccine Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Recombinant DNA Vaccine by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Recombinant DNA Vaccine by Application (2022-2027)
  • 10.3 Recombinant DNA Vaccine Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Recombinant DNA Vaccine by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Recombinant DNA Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Recombinant Protein Vaccine
    Gene-Based Vaccine

    Segment by Application
    Human
    Animal

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Merck
    GSK
    Sanofi
    Zoties
    Elanco
    Boehringer-Ingelheim
    Indian Immunologicals
    Plumbline Life Sciences

    Buy now